Related Experiment Videos
Malignant hyperpyrexia: a rare cause of postoperative death
R J Prescott1, S P Roberts, G Williams
1Department of Histopathology, Christie Hospital and Holt Radium Institute, Withington, Manchester.
Journal of Clinical Pathology
|April 1, 1992
Summary
Central core disease, a genetic disorder, can cause malignant hyperpyrexia. This case highlights potential triggers like anesthesia or postoperative seizures, leading to severe complications.
Area of Science:
- Neurology
- Genetics
- Anesthesiology
Background:
- Malignant hyperpyrexia is a severe pharmacogenetic disorder of skeletal muscle.
- It is triggered by volatile anesthetics and succinylcholine.
- Central core disease is a related genetic myopathy.
Observation:
- A middle-aged male presented with high fever, status epilepticus, and acute renal failure post-surgery.
- Postmortem examination revealed widespread muscle necrosis with hypercontraction bands.
- Muscle enzyme studies and electron microscopy confirmed central core disease.
Findings:
- The patient's presentation suggests a potential episode of malignant hyperpyrexia.
- Central core disease was identified as the underlying genetic condition.
- Possible triggers included isoflurane anesthesia or postoperative seizures.
Implications:
- This case underscores the importance of recognizing central core disease in patients susceptible to malignant hyperpyrexia.
- Anesthesiologists must be aware of potential triggers in patients with genetic myopathies.
- Early diagnosis and avoidance of triggering agents are crucial for patient management.